Khauli R B, Novick A C, Ziegelbaum M
J Vasc Surg. 1985 Jul;2(4):547-51. doi: 10.1067/mva.1985.avs0020547.
From 1962 to 1984 splenorenal bypass was performed in 69 patients with renal artery disease caused by either atherosclerosis (n = 54) or fibrous dysplasia (n = 15). Renal revascularization was performed to control hypertension in 27 patients, to preserve renal function in nine patients, and for both of these reasons in 33 patients. The mean follow-up interval is 5.4 years. Postoperatively hypertension was cured or improved in 52 of 60 patients (87%); the serum creatine level was improved or stable in 37 of 42 patients (88%) who underwent revascularization to preserve renal function. Postoperative graft thrombosis (n = 2) or stenosis (n = 3) occurred in five patients (7%). Splenorenal bypass is an excellent method of revascularization of the left renal artery, particularly for patients with a troublesome aorta that precludes performance of an aortorenal bypass.
1962年至1984年期间，对69例由动脉粥样硬化（n = 54）或纤维发育异常（n = 15）引起的肾动脉疾病患者进行了脾肾分流术。进行肾血管重建术的目的是：27例患者用于控制高血压，9例患者用于保护肾功能，33例患者用于上述两个目的。平均随访时间为5.4年。术后，60例患者中有52例（87%）的高血压得到治愈或改善；在42例为保护肾功能而进行血管重建术的患者中，37例（88%）的血清肌酐水平得到改善或保持稳定。5例患者（7%）术后发生移植血管血栓形成（n = 2）或狭窄（n = 3）。脾肾分流术是左肾动脉血管重建的一种极佳方法，尤其适用于因主动脉病变复杂而无法进行主肾动脉分流术的患者。
